Robert Klein, MD
Obstetrics & Gynecology · Pembroke Pines, FLNPI 1861455503
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by KCI USA, Inc. at 33.0% of the total. Reporting peaked in 2023 at $1,626 and has fallen 89.6% since, to $170 in 2024.
Across 111 payments — averaging $33.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- KCI USA, Inc.$1K
- AbbVie$778
- Exeltis, USA Inc.$650
- Hologic Sales And Service, LLC$192
- Pfizer$134
- Mayne Pharma Commercial LLC$104
- plus $660 from 19 others
Across 36 payments — averaging $6162.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$182K
- Abbott$40K
What the payments were for
- Consulting fees$50013%
- Travel & lodging$1,24133%
- Food & beverage$1,98853%
- Education$140%
- Gifts$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| KCI USA, Inc. | 1 | $1,241 |
| AbbVie(2 entities) | 51 | $778 |
| Exeltis, USA Inc. | 3 | $650 |
| Hologic Sales And Service, LLC | 9 | $192 |
| Pfizer | 7 | $134 |
| Mayne Pharma Commercial LLC | 7 | $104 |
| Bayer | 4 | $99 |
| Therapeuticsmd, Inc. | 4 | $76 |
| Exact Sciences | 3 | $66 |
| Evofem Biosciences, Inc. | 3 | $62 |
| Agile Therapeutics, Inc. | 3 | $48 |
| Kerecis Limited | 1 | $48 |
| Aspira Women's Health Inc | 2 | $35 |
| Coopersurgical, Inc. | 2 | $29 |
| Mylan Pharmaceuticals Inc. | 1 | $25 |
| Mission Pharmacal Company | 1 | $21 |
| Roche Diagnostics Corporation | 1 | $21 |
| Smith+Nephew | 1 | $20 |
| Optumhealth Care Solutions, LLC | 1 | $19 |
| Lupin Inc. | 1 | $17 |
| Ascend Therapeutics US, LLC | 1 | $16 |
| Shield Therapeutics Inc | 1 | $16 |
| BD | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIV.A.C.$1,241
- Slynd$634
How this compares
$3,759 in reported general payments places this provider in the 85th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Pembroke Pines
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.